DE4129005A1 - METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION - Google Patents

METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION

Info

Publication number
DE4129005A1
DE4129005A1 DE19914129005 DE4129005A DE4129005A1 DE 4129005 A1 DE4129005 A1 DE 4129005A1 DE 19914129005 DE19914129005 DE 19914129005 DE 4129005 A DE4129005 A DE 4129005A DE 4129005 A1 DE4129005 A1 DE 4129005A1
Authority
DE
Germany
Prior art keywords
dione
androsten
hydroxy
culture
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19914129005
Other languages
German (de)
Inventor
Alfred Dr Weber
Mario Dr Kewnnecke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19914129005 priority Critical patent/DE4129005A1/en
Priority to PCT/EP1992/001797 priority patent/WO1993005170A1/en
Priority to JP5504864A priority patent/JPH07501689A/en
Priority to EP92917129A priority patent/EP0600946A1/en
Publication of DE4129005A1 publication Critical patent/DE4129005A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/06Hydroxylating
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Described is a method of preparing 14 alpha -hydroxy-4-androstene-3,17-dione with a culture of Curvularia lunata. The method is characterized in that 4-androstene-3,17-dione is suspended in water and the suspension thus obtained fermented.

Description

Die Erfindung betrifft ein Verfahren zur Herstellung von 14αHydroxy-4-androsten-3,17- dion durch Fermentation von 4-Androsten-3,17-dion mit einer Kultur von Curvularia lunata, welches dadurch gekennzeichnet ist, daß man das 4-Androsten-3,17-dion in Wasser suspendiert und die erhaltene Suspension fermentiert.The invention relates to a process for the preparation of 14α-hydroxy-4-androsten-3,17- dion by fermentation of 4-androsten-3,17-dione with a culture of Curvularia lunata, which is characterized in that the 4-androsten-3,17-dione in water suspended and the suspension obtained fermented.

In der SU-Patentschrift 8 01 517 (ref. C.A. 110, 1 33 697u) wird ein Verfahren zur Herstellung von 14α-Hydroxy-4-androsten-3,17-dion durch Fermentation von 4-Androsten-3,17-dion mit einer Kultur von Curvularia lunata beschrieben. In diesem Patent ist aber kein Hinweis enthalten, aus welcher öffentlichen Stammsammlung und unter welcher Nummer dieser Mikroorganismus bezogen werden kann, so daß eine Nacharbeitung des beschriebenen Verfahrens nicht möglich ist. Nach der Lehre dieser Patentschrift löst man das 4-Androsten­ 3,17-dion in Ethanol oder Dimethylformamid, fermentiert 0,5 bis 1,5 g/l Substrat 40 bis 66 Stunden lang und erhält 35 bis 70% offensichtlich sehr stark verunreinigtes 14α-Hydroxy-4- androsten-3,17-dion-Rohprodukt. (Das dem so ist, erkennt man an der Art der Aufarbeitung: Der Fermentationsansatz wird mit Chloroform extrahiert, die Chloroformphase eingeengt und der Rückstand mit Hexan ausgekocht. Das erhaltene Produkt muß also alle extrahierbaren, in Hexan unlöslichen Stoffe enthalten, dies sind nicht nur alle im Fermentationsansatz enthaltenen Steroide sondern auch die entsprechenden Curvularia-Inhaltsstoffe und Medienbestandteile.)SU patent specification 8 01 517 (ref. C.A. 110, 1 33 697u) describes a process for the production of 14α-hydroxy-4-androsten-3,17-dione by fermentation of 4-androsten-3,17-dione with a culture of Curvularia lunata. However, there is no reference in this patent contain from which public trunk collection and under which number this Microorganism can be obtained, so that a rework of the described Procedure is not possible. According to the teaching of this patent, 4-rusting is solved 3,17-dione in ethanol or dimethylformamide, fermented 0.5 to 1.5 g / l substrate 40 to 66 For hours and receives 35 to 70% obviously very contaminated 14α-hydroxy-4- androsten-3,17-dione crude product. (You can tell that from the type of processing: The fermentation batch is extracted with chloroform, the chloroform phase is concentrated and the residue boiled out with hexane. The product obtained must therefore all extractable, in Contain hexane insoluble substances, these are not only all in the fermentation batch contained steroids but also the corresponding Curvularia ingredients and Media components.)

Demgegenüber kann man mit Hilfe des erfindungsgemäßen Verfahrens mehr als 5 g 4-Androsten-3,17-dion pro Liter innerhalb von etwa 12 Stunden reproduzierbar in 14α-Hydroxy-4-androsten-3,17-dion umzuwandeln. Die Ausbeute an Verfahrensprodukt beträgt etwa 60% Reinprodukt.In contrast, more than 5 g can be obtained using the method according to the invention 4-Androsten-3,17-dione per liter reproducible in about 12 hours To convert 14α-hydroxy-4-androsten-3,17-dione. The yield of process product is about 60% pure product.

Das erfindungsgemäße Verfahren wird unter den Fermentationsbedingungen durchgeführt, welche man auch bei den bekannten mikrobiologischen Umwandlungen von Substraten mit Curvularia lunata Kulturen anwendet.The process according to the invention is carried out under the fermentation conditions, which is also used in the known microbiological conversions of substrates Curvularia lunata uses cultures.

Unter den für diesen Mikroorganismus üblicherweise verwendeten Kulturbedingungen werden in einem geeigneten Nährmedium unter Belüften Submerskulturen angezüchtet. Dann setzt man der Kultur eine wäßrige Suspension des 4-Androsten-3,17-dion zu und fementiert bis eine maximale Substratumwandlung erreicht ist. Under the culture conditions usually used for this microorganism are grown in a suitable nutrient medium with aeration submerged cultures. Then an aqueous suspension of 4-androsten-3,17-dione is added to the culture and cemented until a maximum substrate conversion is reached.  

Die wäßrige Suspension des 4-Androsten-3,17-dions läßt sich in einfacher Weise herstellen, indem man beispielsweise dieser Substanz mit der zweifachen bei fünffachen Menge Wasser unter Zusatz eines nichtionischen Tensids in einer Kugelmühle mahlt bis sie eine Korngröße von ca. 1 bis 5 µm besitzt. Geeignete Tenside sind beispielsweise Ethylenoxidaddukte oder Fettsäureester von Polyglykolen. Als geeignete Tenside seien beispielsweise die handelsüblichen Netzmittel wie Tegin®, Tween®, oder Span® genannt.The aqueous suspension of 4-androsten-3,17-dione can be prepared in a simple manner, for example by using this substance twice with five times the amount of water with the addition of a nonionic surfactant in a ball mill grinds until it has a grain size from about 1 to 5 µm. Suitable surfactants are, for example, ethylene oxide adducts or Fatty acid esters of polyglycols. Suitable surfactants are, for example commercially available wetting agents such as Tegin®, Tween®, or Span®.

Nach erfolgter Fermentation wird die Kultur in üblicher Weise aufbereitet, beispielsweise indem man sie mit einem in Wasser schwer löslichen Alkohol, Keton oder Ester extrahiert, den Extrakt einengt und den erhaltenen Rückstand durch Chromatographie und/oder Kristallisation aufreinigt.After fermentation has taken place, the culture is prepared in the usual manner, for example by extracting them with an alcohol, ketone or ester that is difficult to dissolve in water, the extract is concentrated and the residue obtained by chromatography and / or Purifies crystallization.

Die Weiterverarbeitung des erhaltenen 14α-Hydroxy-4-androsten-3,17-dions zu pharmakologisch wirksamen Steroiden ist bekannt oder erfolgt nach an sich bekannten Verfahren (J. Amer. Chem. Soc., 91, 1969, 1228 ff; EP-A 03 00 062 und weitere).The processing of the 14α-hydroxy-4-androsten-3,17-dione obtained pharmacologically active steroids is known or is carried out according to known Process (J. Amer. Chem. Soc., 91, 1969, 1228 ff; EP-A 03 00 062 and others).

Das nachfolgende Ausführungsbeispiel dient zur näheren Erläuterung des erfindungsgemäßen Verfahrens. The following embodiment serves to explain the invention Procedure.  

Beispielexample

  • a) Ein 2 l Erlenmeyer mit 1 l sterilem Nährmedium enthaltend
    1% Cornsteep liqour,
    1,25% Sojapuder,
    - eingestellt auf pH 6,2 -
    wird mit 5 ml einer Suspension einer Curvularia lunata NRRL 2380-Kultur beimpft und 60 Stunden bei 30°C mit 180 Umdrehungen pro Minute geschüttelt.
    a) Containing a 2 l Erlenmeyer with 1 l sterile nutrient medium
    1% Cornsteep liqour,
    1.25% soy powder,
    - adjusted to pH 6.2 -
    is inoculated with 5 ml of a suspension of a Curvularia lunata NRRL 2380 culture and shaken for 60 hours at 30 ° C. at 180 revolutions per minute.
  • b) Ein 50 l-Fermenter mit 30 l steriler Nährlösung wie unter a) angegeben wird mit 1 l der Curvularia lunata-Anzuchtkultur beimpft und 18 Stunden bei 30°C unter Belüftung von 2 m3 pro Stunde und Rühren mit 220 Umdrehungen pro Minute inkubiert.b) A 50 l fermenter with 30 l of sterile nutrient solution as indicated under a) is inoculated with 1 l of the Curvularia lunata culture and incubated for 18 hours at 30 ° C. with aeration of 2 m 3 per hour and stirring at 220 revolutions per minute .
  • c) Ein 50 l-Fermenter mit 40 l steriler Nährlösung enthaltend
    1% Cornsteep liqour,
    1,25% Sojapuder,
    0,3% β-Cyclodextrin
    - eingestellt auf pH 6,2 -
    c) A 50 l fermenter containing 40 l of sterile nutrient solution
    1% Cornsteep liqour,
    1.25% soy powder,
    0.3% β-cyclodextrin
    - adjusted to pH 6.2 -

wird mit 4 l der Curvularia lunata-Vorkultur beimpft und unter Belüftung von 2,4 m3 pro Stunde und Rühren mit 150 Umdrehungen pro Minute bei 30°C 7 Stunden inkubiert.is inoculated with 4 l of the Curvularia lunata preculture and incubated with aeration of 2.4 m 3 per hour and stirring at 150 revolutions per minute at 30 ° C. for 7 hours.

Dann setzt man der Kultur 250 g 4-Androstaen-3,17-dion als Mahlung in 1000 ml Wasser mit 25 g Tween® 80 zu und fermentiert weitere 12 Stunden lang unter Rühren mit 220 Umdrehungen pro Minute und einer Belüftung von 2,4 m3 pro Stunde.Then 250 g of 4-androstaen-3,17-dione are added to the culture as a grinding in 1000 ml of water with 25 g of Tween® 80 and fermentation is continued for a further 12 hours with stirring at 220 revolutions per minute and aeration of 2.4 m 3 per hour.

  • d) Nach erfolgter Fermentation wird die Kulturbrühe dreimal mit je 20 l Methylisobutylketon extrahiert, der Extrakt im Rotationsverdampfer bei max. 50°C unter Vakuum eingeengt. Anschließend erfolgt eine Reinigung durch Chromatographie über eine Kieselgelsäule mittels Hexan-Aceton-Gradienten.d) After fermentation, the culture broth is three times with 20 l of methyl isobutyl ketone extracted, the extract in a rotary evaporator at max. Concentrated 50 ° C under vacuum. It is then purified by chromatography on a silica gel column using a hexane-acetone gradient.

Man erhält 150 g 14α:-Hydroxy-androsta-4-en-3,17-dion vom Schmelzpunkt 257-259°C.150 g of 14α: -hydroxy-androsta-4-en-3,17-dione with a melting point of 257-259 ° C. are obtained.

Claims (2)

1. Verfahren zur Herstellung von 14α:-Hydroxy-4-androsten-3,17-dion durch Fermentation von 4-Androsten-3,17-dion mit einer Kultur von Curvularia lunata, dadurch gekenn­ zeichnet, daß man das 4-Androsten-3,17-dion in Wasser suspendiert und die erhaltenen Suspensionen fermentiert.1. Process for the preparation of 14α: -hydroxy-4-androstene-3,17-dione by fermentation of 4-androstene-3,17-dione with a culture of Curvularia lunata, characterized in that the 4-androstene- 3,17-dione suspended in water and the suspensions obtained fermented. 2. Verfahren zur Herstellung von 14α-Hydroxy-4-androsten-3,17-dion gemäß Patentanspruch 1, dadurch gekennzeichnet, daß man zur Fermentation eine Kultur von Curvularia lunata NRRL 2380 verwendet.2. Process for the preparation of 14α-hydroxy-4-androsten-3,17-dione according to Claim 1, characterized in that a culture of Curvularia lunata NRRL 2380 used.
DE19914129005 1991-08-28 1991-08-28 METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION Withdrawn DE4129005A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19914129005 DE4129005A1 (en) 1991-08-28 1991-08-28 METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION
PCT/EP1992/001797 WO1993005170A1 (en) 1991-08-28 1992-08-07 METHOD OF PREPARING 14α-HYDROXY-4-ANDROSTENE-3,17-DIONE
JP5504864A JPH07501689A (en) 1991-08-28 1992-08-07 Method for producing 14α-hydroxy-4-androstene-3,17-dione
EP92917129A EP0600946A1 (en) 1991-08-28 1992-08-07 METHOD OF PREPARING 14$g(a)-HYDROXY-4-ANDROSTENE-3,17-DIONE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19914129005 DE4129005A1 (en) 1991-08-28 1991-08-28 METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION

Publications (1)

Publication Number Publication Date
DE4129005A1 true DE4129005A1 (en) 1993-03-04

Family

ID=6439592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19914129005 Withdrawn DE4129005A1 (en) 1991-08-28 1991-08-28 METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION

Country Status (4)

Country Link
EP (1) EP0600946A1 (en)
JP (1) JPH07501689A (en)
DE (1) DE4129005A1 (en)
WO (1) WO1993005170A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1267758A (en) * 1956-12-19 1961-07-28 Merck & Co Inc Preparation process
DE3873200T2 (en) * 1987-02-06 1993-02-25 Snow Brand Milk Products Co Ltd NEW ANDROST-4-EN-3,17-DION DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.

Also Published As

Publication number Publication date
EP0600946A1 (en) 1994-06-15
JPH07501689A (en) 1995-02-23
WO1993005170A1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
EP0437555B1 (en) Process for the racemic separation of 4-aryl-2-oxo-pyrrolidine-3-carboxylic acid esters
DE4129005A1 (en) METHOD FOR PRODUCING 14 (ALPHA) -HYDROXY-4-ANDROSTEN-3,17-DION
EP0027829B1 (en) Process for the preparation of 9-alpha-hydroxy-4-androstene-3,17-dione
EP0632836B1 (en) Process for producing 17alpha-hydroxy-3-methoxy-8,14-seco-1,3,5(10),9(11) estratetraene-14-one
EP0505514B1 (en) PROCESS FOR PRODUCING $g(b)-CARBOLINE DERIVATES
EP0002535B1 (en) Process for the preparation of 21-hydroxy-20-methyl pregnanes
DE2652377B2 (en) Process for the preparation of 7 a ß-methylhexahydro-1, (5) -indan (di) one compounds
EP0028309B1 (en) Process for the preparation of 11-alpha-hydroxy-20-alpha-hydroxymethyl-1,4-pregnadiene-3-one
EP0496846B1 (en) Method of preparing 17-oxosteroids
US5391484A (en) Process for the production of 4-pregnene-3,20-dione and its derivatives using mycobacterium NRRL B-3805
EP0496854B1 (en) Method for preparation of 20-METHYL-5,7-PREGNADIENE-3$g(b),21-DIOL DERIVATIVES
EP0261187A1 (en) PROCESS FOR THE PRODUCTION OF 17a$g(a)-HYDROXY-D-HOMO-1,4-PREGNADIENE-3,20-DION
EP0272201A1 (en) Stereospecific ketoreduction of bicyclooctanedione-carboxylic-acid esters by microorganisms
WO1996015253A1 (en) Process for producing 1-hydroxymethyl-1.4-androstadiene-3.17-dione
DE1793750C3 (en) Process for the preparation of fluorine compounds of the pregnancy series
DE2901563A1 (en) 12-Beta-hydroxy-17-alpha-acyloxy-4-pregnene-3,20-di:ione cpds. - prepd. by microbiological hydroxylation of corresp. unsubstituted steroid(s) with Calonectria decora
US4237220A (en) Process for preparing 9α-hydroxy-4-androstene-3,17-dione
AT237811B (en) Process for the microbiological hydrogenation, dehydrogenation, hydroxylation and side chain cleavage of steroids
DE3544662A1 (en) METHOD FOR PRODUCING 4-ANDROSTEN-3,17-DION AND 1,4-ANDROSTADIEN-3,17-DION
DE2203535A1 (en) 16-alpha-methyl-6, 20-dioxopregnane derivs - useful as inters for active steroids
DE2901562A1 (en) 17-beta-hydroxy-18-methyl-4,15-oestra-di:en-3-one - has progestative, oestrogenic and anti-hypercholesterolaemic activity
DE1191371B (en) Process for the preparation of delta 1,4,12-13, 17-seco-androstatriene-3, 11-dione-17-caonic acid compounds and 11-keto-delta 1-dehydrotestolo-lactone compounds
DE1062699B (en) Process for the 11-hydroxylation of steroid compounds
DE1181703B (en) Process for the microbiological conversion of steroids and fatty acids
DE1101413B (en) Process for the hydroxylation of 7-deoxysteroids of the pregnane series

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: SCHERING AG, 13353 BERLIN, DE

8130 Withdrawal